Greece's Prime Minister Alexis Tsipras is to hold an emergency government meeting at midday London time to discuss the failure of the latest round of discussions with its creditors to help stop the country tumbling into bankruptcy.Talks between Greece and its creditors over the weekend yet again failed to resolve the impasse over reforms, with European officials blaming Greece for failing to offer concessions in return for a final tranche of desperately-needed financial aid. Standard Pacific (SPF) and Ryland Group Inc (RYL) said they would merge to become the fourth-largest homebuilder in the United States. The merged company would have a market capitalization of about $5.2 billion and an enterprise value of about $8.2 billion and would own or control about 74,000 homesites, the companies said in a statement on Sunday. United Technologies (UTX) said on Monday it plans to sell or spin off helicopter maker Sikorsky Aircraft by the end of the third quarter this year after a strategic review of the business. The unit, best known as the maker of Black Hawk helicopters, is one of the largest suppliers in the sector, with $7.5 billion in sales in 2014. It is the main supplier of helicopters to the U.S. Defense Department.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.